🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
April 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — April 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(869)
All (869)
Buys (64)
Sells (805)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
HeartBeam, Inc.
(BEAT)
Ortigas-Wedekind Marga
— Director
Apr 16, 2026
Purchase
Shares
25,000
Price
$0.80
Total Value
$20.00K
Shares Held After
137,293
% of Holdings
18.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
HeartBeam, Inc.
(BEAT)
ENO Robert Paul
— President
Apr 16, 2026
Purchase
Shares
12,500
Price
$0.80
Total Value
$10.00K
Shares Held After
36,742
% of Holdings
34.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
HeartBeam, Inc.
(BEAT)
STROME MARK E
— Director
Apr 16, 2026
Purchase
Shares
750,000
Price
$0.80
Total Value
$600.00K
Shares Held After
3,650,000
% of Holdings
20.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
HeartBeam, Inc.
(BEAT)
JAFF MICHAEL R
— Director
Apr 16, 2026
Purchase
Shares
31,250
Price
$0.80
Total Value
$25.00K
Shares Held After
31,250
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
HeartBeam, Inc.
(BEAT)
Vajdic Branislav
— Director
Apr 16, 2026
Purchase
Shares
31,250
Price
$0.80
Total Value
$25.00K
Shares Held After
909,914
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
HeartBeam, Inc.
(BEAT)
Ferrari Richard
— Director
Apr 16, 2026
Purchase
Shares
62,500
Price
$0.80
Total Value
$50.00K
Shares Held After
291,636
% of Holdings
21.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
HeartBeam, Inc.
(BEAT)
Cruickshank Tim
— CFO
Apr 16, 2026
Purchase
Shares
31,250
Price
$0.80
Total Value
$25.00K
Shares Held After
72,230
% of Holdings
43.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Apr 16, 2026
Sale
Shares
1,850
Price
$54.88
Total Value
$101.52K
Shares Held After
117,000
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Apr 16, 2026
Sale
Shares
5,190
Price
$54.56
Total Value
$283.14K
Shares Held After
118,850
% of Holdings
4.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
RUBINSTEIN JULIE
— President and COO
Apr 16, 2026
Sale
Shares
19,060
Price
$14.18
Total Value
$270.27K
Shares Held After
408,160
% of Holdings
4.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Tariq Musa
— Director
Apr 16, 2026
Sale
Shares
116
Price
$84.83
Total Value
$9.84K
Shares Held After
8,528
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sionna Therapeutics, Inc.
(SION)
ORBIMED ADVISORS LLC
— Director
Apr 16, 2026
Sale
Shares
226,906
Price
$45.34
Total Value
$10.29M
Shares Held After
3,020,119
% of Holdings
7.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sionna Therapeutics, Inc.
(SION)
Thompson Peter A.
— Director
Apr 16, 2026
Sale
Shares
226,906
Price
$45.34
Total Value
$10.29M
Shares Held After
3,020,119
% of Holdings
7.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Aura Biosciences, Inc.
(AURA)
Kilroy Conor
— Chief Legal Officer and Secretary.
Apr 16, 2026
Sale
Shares
11,738
Price
$7.02
Total Value
$82.40K
Shares Held After
217,835
% of Holdings
5.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Apr 16, 2026
Sale
Shares
1,294
Price
$578.21
Total Value
$748.20K
Shares Held After
45,172
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Apr 16, 2026
Sale
Shares
3,366
Price
$577.39
Total Value
$1.94M
Shares Held After
46,466
% of Holdings
6.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Apr 16, 2026
Sale
Shares
1,800
Price
$576.38
Total Value
$1.04M
Shares Held After
49,832
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Apr 16, 2026
Sale
Shares
1,640
Price
$575.37
Total Value
$943.61K
Shares Held After
51,632
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Apr 16, 2026
Sale
Shares
200
Price
$574.03
Total Value
$114.81K
Shares Held After
53,272
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Clene Inc.
(CLNN)
Ugwumba Chidozie
— 10% Owner
Apr 15, 2026
Sale
Shares
6,374
Price
$6.48
Total Value
$41.30K
Shares Held After
395,517
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
PARSHALL B LYNNE
— Director
Apr 15, 2026
Sale
Shares
534
Price
$76.97
Total Value
$41.10K
Shares Held After
51,344
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
PARSHALL B LYNNE
— Director
Apr 15, 2026
Sale
Shares
4,466
Price
$76.19
Total Value
$340.26K
Shares Held After
51,878
% of Holdings
7.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
GOLDSMITH MARK A
— Director
Apr 15, 2026
Sale
Shares
120,000
Price
$150.09
Total Value
$18.01M
Shares Held After
276,698
% of Holdings
30.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Septerna, Inc.
(SEPN)
Bhatt Elizabeth
— President and COO
Apr 15, 2026
Sale
Shares
326
Price
$25.86
Total Value
$8.43K
Shares Held After
174,209
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Septerna, Inc.
(SEPN)
Bhatt Elizabeth
— President and COO
Apr 15, 2026
Sale
Shares
1,101
Price
$25.24
Total Value
$27.79K
Shares Held After
174,535
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Septerna, Inc.
(SEPN)
Bhatt Elizabeth
— President and COO
Apr 15, 2026
Sale
Shares
2,573
Price
$23.76
Total Value
$61.12K
Shares Held After
175,636
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Lillie James Woodruff
— Chief Scientific Officer
Apr 15, 2026
Sale
Shares
1,730
Price
$26.82
Total Value
$46.40K
Shares Held After
297,940
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Kreitzer Anatol
— Chief Discovery Officer
Apr 15, 2026
Sale
Shares
3,316
Price
$26.61
Total Value
$88.24K
Shares Held After
256,612
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
GILLIS JONATHAN
— CAAO and PAO
Apr 15, 2026
Sale
Shares
3,590
Price
$26.61
Total Value
$95.53K
Shares Held After
251,054
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Setia Vishwas
— Chief Financial Officer
Apr 15, 2026
Sale
Shares
2,806
Price
$26.87
Total Value
$75.40K
Shares Held After
392,743
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Hanson Kristopher
— General Counsel
Apr 15, 2026
Sale
Shares
1,529
Price
$26.80
Total Value
$40.98K
Shares Held After
190,463
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARDELYX, INC.
(ARDX)
RAAB MICHAEL
— Director
Apr 15, 2026
Sale
Shares
41,668
Price
$6.29
Total Value
$261.95K
Shares Held After
1,795,614
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Kersten Dirk
— Director
Apr 15, 2026
Sale
Shares
81,840
Price
$20.27
Total Value
$1.66M
Shares Held After
4,562,546
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Malenka Robert C.
— Director
Apr 15, 2026
Sale
Shares
8,593
Price
$26.90
Total Value
$231.15K
Shares Held After
316,466
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Kroeger Christopher A.
— Director
Apr 15, 2026
Sale
Shares
9,135
Price
$26.93
Total Value
$246.01K
Shares Held After
1,640,616
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
SKIBSTED RUSSELL
— Chief Financial Officer
Apr 15, 2026
Purchase
Shares
1,984
Price
$2.97
Total Value
$5.89K
Shares Held After
4,308
% of Holdings
46.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALVELLA THERAPEUTICS, INC.
(PVLA)
Goin Kathleen
— Chief Operating Officer
Apr 15, 2026
Sale
Shares
100
Price
$130.33
Total Value
$13.03K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALVELLA THERAPEUTICS, INC.
(PVLA)
Goin Kathleen
— Chief Operating Officer
Apr 15, 2026
Sale
Shares
639
Price
$129.17
Total Value
$82.54K
Shares Held After
100
% of Holdings
86.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALVELLA THERAPEUTICS, INC.
(PVLA)
Goin Kathleen
— Chief Operating Officer
Apr 15, 2026
Sale
Shares
561
Price
$128.23
Total Value
$71.94K
Shares Held After
739
% of Holdings
43.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALVELLA THERAPEUTICS, INC.
(PVLA)
Goin Kathleen
— Chief Operating Officer
Apr 15, 2026
Sale
Shares
1,500
Price
$127.13
Total Value
$190.69K
Shares Held After
1,300
% of Holdings
53.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALVELLA THERAPEUTICS, INC.
(PVLA)
Goin Kathleen
— Chief Operating Officer
Apr 15, 2026
Sale
Shares
1,502
Price
$125.96
Total Value
$189.20K
Shares Held After
2,800
% of Holdings
34.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Foff Erin Pennock
— Chief Medical Officer
Apr 15, 2026
Sale
Shares
2,044
Price
$26.84
Total Value
$54.86K
Shares Held After
401,946
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bicara Therapeutics Inc.
(BCAX)
Cohlhepp Ryan
— Director
Apr 15, 2026
Sale
Shares
4,500
Price
$23.01
Total Value
$103.53K
Shares Held After
196,141
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bicara Therapeutics Inc.
(BCAX)
Cohlhepp Ryan
— Director
Apr 15, 2026
Sale
Shares
8,000
Price
$23.01
Total Value
$184.06K
Shares Held After
200,641
% of Holdings
3.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Guy Wendy
— Chief Administrative Officer
Apr 15, 2026
Purchase
Shares
1,583
Price
$2.97
Total Value
$4.70K
Shares Held After
4,693
% of Holdings
33.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Young David
— Director
Apr 15, 2026
Purchase
Shares
1,545
Price
$2.97
Total Value
$4.59K
Shares Held After
12,107
% of Holdings
12.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Lin Patrick
— Chief Business - Strategy Off
Apr 15, 2026
Purchase
Shares
1,369
Price
$2.97
Total Value
$4.07K
Shares Held After
4,725
% of Holdings
29.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Ng George K
— Director
Apr 15, 2026
Purchase
Shares
1,843
Price
$2.97
Total Value
$5.47K
Shares Held After
5,492
% of Holdings
33.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Whitehawk Therapeutics, Inc.
(WHWK)
Giacobello Scott M.
— CHIEF FINANCIAL OFFICER
Apr 15, 2026
Sale
Shares
77,000
Price
$3.86
Total Value
$297.22K
Shares Held After
436,824
% of Holdings
15.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Bigora Sian
— Chief Development Officer
Apr 15, 2026
Purchase
Shares
1,799
Price
$2.97
Total Value
$5.34K
Shares Held After
5,510
% of Holdings
32.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 51–100 of 869 transactions (page 2 of 18)
Version: v26.3.33